BOULDER, Colo., Oct. 4 /PRNewswire-FirstCall/ -- Array BioPharma Inc.
(Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E.
Conway, will speak at the BIO Emerging Company Investor Forum on October 14 in
San Francisco. The public is welcome to participate in the conference through
an audio webcast on the Array BioPharma website.
Event: BIO Emerging Company Investor Forum
Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Thursday, October 14, 2004
Time: 10:50 am Pacific Time
Location: The Palace Hotel, San Francisco
Audio Webcast: www.arraybiopharma.com
About Array BioPharma:
Array BioPharma is a biopharmaceutical company focused on the discovery,
development and commercialization of orally active drugs to address
significant unmet medical needs. Our proprietary drug development pipeline is
primarily focused on the treatment of cancer and inflammatory disease and
includes several small molecule drug candidates that are designed to regulate
targets in therapeutically important biologic pathways. In addition, leading
pharmaceutical and biotechnology companies access our drug discovery
technologies and expertise through collaborations to design, create, optimize
and evaluate drug candidates across a broad range of therapeutic areas. For
more information on Array, please go to www.arraybiopharma.com.
SOURCE Array BioPharma Inc.
-0- 10/04/2004
/CONTACT:
Tricia Haugeto of Array BioPharma Inc.
303-386-1193,
thaugeto@arraybiopharma.com
/Web site: http://www.arraybiopharma.com /
(ARRY)
10/04/2004 16:30 EDT http://www.prnewswire.com
